Genomeditech

Genomeditech is a biotechnology company headquartered in Shanghai, China, specializing in the development of gene and cell therapy (GCT) solutions. The company operates as both a therapeutic developer and a service provider, offering high-quality viral vectors, CRISPR/Cas9 gene-editing tools, and CDMO services for the global life sciences community. Their internal pipeline includes innovative CAR-T and CAR-NK cell therapies aimed at treating hematological malignancies and solid tumors. By leveraging their proprietary vector packaging and cell engineering platforms, Genomeditech aims to accelerate the transition of genomic research into clinical treatments. The company also provides a comprehensive suite of molecular biology reagents and services to support academic and industrial research.